Oral estrogen hormone therapy linked to increased risk of gallbladder surgery in menopausal women

Oral estrogen therapy for menopausal women is associated with an increased risk of gallbladder surgery, according to a large-scale study of more than 70 000 women in France published in CMAJ (Canadian Medical Association Journal)

Women who took estrogen therapy through or gels did not appear to be at increased risk.

Gallstone disease is common in developed countries, and women over age 50 are most at risk. Other risk factors include obesity, diabetes, high cholesterol, and having given birth to two or more children.

A large study of 70 928 menopausal women in France between 1992 and 2008 looked at whether hormone therapy increased the risk of (cholecystectomy) for complications of gallstones. In France, hormonal therapy is usually administered topically rather than orally. North America and the United Kingdom prefer oral hormone therapies.

"In this large French , we found that the risk of cholecystectomy was increased among women exposed to oral estrogen regiments for menopausal hormone therapy, especially oral regimens without progestagen," writes Dr. Antoine Racine, Institut national de la santé et de la recherche médicale (INSERM) and Université Paris Sud, with coauthors. "Other types of menopausal hormone therapy were not associated with an increased risk of cholecystectomy."

"Complicated should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with menopausal hormone therapy," the authors conclude.

In a related commentary, Dr. Bette Liu, Faculty of Medicine, University of , Sydney, Australia, writes that the findings of this study support current recommendations for minimizing doses and duration of hormone therapy for menopausal symptoms. However, if hormone therapy is considered necessary, transdermal formulations (such as patches or gels) may have fewer adverse effects than oral formulations.

"Unfortunately there are no large clinical trials comparing transdermal and oral therapies, and such trials will probably never be conducted," she writes. "Evidence to guide recommendations on the best route of hormone administration for individual women and prescribers will thus be limited to the growing volume of observational data. These data suggest that the overall risk–benefit profile of transdermal menopausal hormone therapy makes it a more attractive option than oral therapies."

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.121490
Commentary: www.cmaj.ca/lookup/doi/10.1503/cmaj.130004

add to favorites email to friend print save as pdf

Related Stories

Menopausal hormone therapy may increase risk of ovarian cancer

Nov 09, 2010

Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention ...

VTE risk varies by hormone therapy formulation

Sep 18, 2012

(HealthDay)—The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral ...

Recommended for you

Web surfing to weigh up bariatric surgery options

5 hours ago

Obese people considering weight-reducing bariatric surgery are only topped by pregnant women when it comes to how often they turn to the Internet for health advice. While most use it to read up on relevant procedures and ...

Device for guided surgery of deviations in long bones

10 hours ago

CEU-UCH Cardenal Herrera University patented a device for surgeries to correct deviations in long bones. The research team used the 3D simulation of an affected bone to determine the mathematical formula ...

New algorithm will allow better heart surgery

11 hours ago

A new technique to help surgeons find the exact location of heart defects could save lives, help them to treat patients more effectively and save health service cash.

Hard search for less invasive brain surgery leads to eyelid

Jan 26, 2015

Doctor after doctor said removing the tumor causing Pamela Shavaun Scott's unrelenting headaches would require cutting open the top of her skull and pushing aside her brain. Then one offered a startling shortcut—operating ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.